Please direct all media inquiries to Gina Cella at gcella@ataaction.org or 781-799-3137
Press Release
TELEHEALTH WINS REPRIEVE: ATA AND ATA ACTION COMMEND DEA AND SAMHSA FOR EXTENSION OF FLEXIBILITIES FOR REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES
WASHINGTON, DC, MAY 9, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement in response to the Drug Enforcement Administration’s (DEA) and Substance Abuse and Mental Health Services Administration’s (SAMHSA) temporary...
ATA AND ATA ACTION RESPOND TO DEA’S EXTENSION OF COVID-19 TELEMEDICINE FLEXIBILITIES FOR REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES
WASHINGTON, DC, MAY 4, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement in response to the Drug Enforcement Administration’s (DEA) extension of COVID-19 telemedicine flexibilities for the remote prescription of...
ATA ACTION SUBMITS COMPREHENSIVE RECOMMENDATIONS TO DEA ON PROPOSED RULES REGARDING REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES
WASHINGTON, DC, MARCH 29, 2023 – ATA Action officially submitted comprehensive comments regarding the Drug Enforcement Administration (DEA)’s proposed rules regarding the remote prescribing of controlled substances. In two letters to the DEA, ATA Action outlined...